A novel gene therapy trial will bathe the brains of people who carry two copies of high-risk APOE4 with a huge dose of protective APOE2 — a strategy that reduced abnormal beta-amyloid in mice. (MIT Technology Review)
Also new in Alzheimer’s trials: the 40-center study of Biohaven’s investigational drug troriluzole is underway. (Forbes)
Can hyperbaric oxygen treat Alzheimer’s? Two researchers say yes. (Forbes)
People with autism died at twice the rate of the general population in Australia, largely by injury or poisoning — including suicide — or nervous system disorders such as seizures. (Sydney Morning Herald)
Tissue transplant patients had a 37% lower risk of Parkinson’s disease than other Medicare patients. (Parkinsonism and Related Disorders)
A palm-worn device may help track changes in rigidity in Parkinson’s patients after deep brain stimulation. (Journal of Neuroscience Methods)
A guided walk or a solo free-climb? What needs to be taught in neurology clerkships. (Neurology)
How much dementia patients need to know: The New Yorker reprints work by the late Oliver Sacks.
The FDA issued “leapfrog” guidance about brain-computer interface technology for patients with paralysis or amputation.
How do brains keep memories in the right order? (Wired)